|
Volumn 31, Issue 8, 2001, Pages 2277-2283
|
Sperm protein 17 (Sp17) in multiple myeloma: Opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk
|
Author keywords
Donor CTL; Graft versus host disease; Graft versus myeloma; Sperm protein 17
|
Indexed keywords
CD8 ANTIGEN;
GAMMA INTERFERON;
HLA A1 ANTIGEN;
HLA ANTIGEN CLASS 1;
HLA ANTIGEN CLASS 2;
HLA B27 ANTIGEN;
INTERLEUKIN 4;
POLYCLONAL ANTIBODY;
RECOMBINANT PROTEIN;
SPERM PROTEIN 17;
TUMOR ANTIGEN;
UNCLASSIFIED DRUG;
ARTICLE;
CANCER PATIENT;
CELL SPECIFICITY;
CELL TRANSFORMATION;
CONCENTRATION (PARAMETERS);
CONTROLLED STUDY;
CYTOLYSIS;
CYTOTOXIC T LYMPHOCYTE;
CYTOTOXICITY;
DENDRITIC CELL;
DONOR;
EPSTEIN BARR VIRUS;
FEMALE;
FLOW CYTOMETRY;
GRAFT VERSUS HOST REACTION;
HUMAN;
HUMAN CELL;
IMMUNIZATION;
LYMPHOBLASTOID CELL;
LYMPHOCYTE TRANSFUSION;
MALE;
MOLECULAR RECOGNITION;
MULTIPLE MYELOMA;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN PROCESSING;
RISK ASSESSMENT;
STEM CELL TRANSPLANTATION;
T LYMPHOCYTE;
TARGET CELL;
TUMOR CELL;
ANTIGEN PRESENTATION;
ANTIGENS, NEOPLASM;
ANTIGENS, SURFACE;
CARRIER PROTEINS;
CELLS, CULTURED;
CYTOKINES;
CYTOTOXICITY, IMMUNOLOGIC;
DENDRITIC CELLS;
DISEASE SUSCEPTIBILITY;
ESCHERICHIA COLI;
FLOW CYTOMETRY;
GRAFT VS HOST DISEASE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HISTOCOMPATIBILITY ANTIGENS CLASS I;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
MALE;
MULTIPLE MYELOMA;
RECOMBINANT PROTEINS;
SUBSTRATE SPECIFICITY;
T-LYMPHOCYTES, CYTOTOXIC;
TUMOR CELLS, CULTURED;
|
EID: 0034856410
PISSN: 00142980
EISSN: None
Source Type: Journal
DOI: 10.1002/1521-4141(200108)31:8<2277::AID-IMMU2277>3.0.CO;2-Z Document Type: Article |
Times cited : (43)
|
References (15)
|